FDA Orange Book · active-ingredient family
Hydroflumethiazide
Hydroflumethiazide is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:SALURON · NDA 011949
1
Brand (NDA)
4
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SALURONRLD | SHIRE LLC | NDA 011949 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (4)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| HYDROFLUMETHIAZIDE | PAR PHARM | ANDA 088850 | — | May 31, 1985 | |
| HYDROFLUMETHIAZIDE | WATSON LABS | ANDA 088528 | — | Aug 15, 1984 | |
| HYDROFLUMETHIAZIDE | WATSON LABS | ANDA 088031 | — | Apr 06, 1983 | |
| DIUCARDIN | WYETH AYERST | ANDA 083383 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Hydroflumethiazide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

